Literature DB >> 19602583

Prolonged maternal amino acid infusion in late-gestation pregnant sheep increases fetal amino acid oxidation.

Paul J Rozance1, Michelle M Crispo, James S Barry, Meghan C O'Meara, Mackenzie S Frost, Kent C Hansen, William W Hay, Laura D Brown.   

Abstract

Protein supplementation during human pregnancy does not improve fetal growth and may increase small-for-gestational-age birth rates and mortality. To define possible mechanisms, sheep with twin pregnancies were infused with amino acids (AA group, n = 7) or saline (C group, n = 4) for 4 days during late gestation. In the AA group, fetal plasma leucine, isoleucine, valine, and lysine concentrations were increased (P < 0.05), and threonine was decreased (P < 0.05). In the AA group, fetal arterial pH (7.365 +/- 0.007 day 0 vs. 7.336 +/- 0.012 day 4, P < 0.005), hemoglobin-oxygen saturation (46.2 +/- 2.6 vs. 37.8 +/- 3.6%, P < 0.005), and total oxygen content (3.17 +/- 0.17 vs. 2.49 +/- 0.20 mmol/l, P < 0.0001) were decreased on day 4 compared with day 0. Fetal leucine disposal did not change (9.22 +/- 0.73 vs. 8.09 +/- 0.63 micromol x min(-1) x kg(-1), AA vs. C), but the rate of leucine oxidation increased 43% in the AA group (2.63 +/- 0.16 vs. 1.84 +/- 0.24 micromol x min(-1) x kg(-1), P < 0.05). Fetal oxygen utilization tended to be increased in the AA group (327 +/- 23 vs. 250 +/- 29 micromol x min(-1) x kg(-1), P = 0.06). Rates of leucine incorporation into fetal protein (5.19 +/- 0.97 vs. 5.47 +/- 0.89 micromol x min(-1) x kg(-1), AA vs. C), release from protein breakdown (4.20 +/- 0.95 vs. 4.62 +/- 0.74 micromol x min(-1) x kg(-1)), and protein accretion (1.00 +/- 0.30 vs. 0.85 +/- 0.25 micromol x min(-1) x kg(-1)) did not change. Consistent with these data, there was no change in the fetal skeletal muscle ubiquitin ligases MaFBx1 or MuRF1 or in the protein synthesis regulators 4E-BP1, eEF2, eIF2alpha, and p70(S6K). Decreased concentrations of certain essential amino acids, increased amino acid oxidation, fetal acidosis, and fetal hypoxia are possible mechanisms to explain fetal toxicity during maternal amino acid supplementation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602583      PMCID: PMC2739698          DOI: 10.1152/ajpendo.00192.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  47 in total

1.  Umbilical amino acid uptake at increasing maternal amino acid concentrations: effect of a maternal amino acid infusate.

Authors:  S Ronzoni; A M Marconi; I Cetin; C L Paolini; C Teng; G Pardi; F C Battaglia
Journal:  Am J Obstet Gynecol       Date:  1999-08       Impact factor: 8.661

2.  Amino acids stimulate translation initiation and protein synthesis through an Akt-independent pathway in human skeletal muscle.

Authors:  Zhenqi Liu; Linda A Jahn; Liping Wei; Wen Long; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

3.  A randomized controlled trial of prenatal nutritional supplementation in New York City.

Authors:  D Rush; Z Stein; M Susser
Journal:  Pediatrics       Date:  1980-04       Impact factor: 7.124

4.  Effects of branched-chain amino acids on placental amino acid transfer and insulin and glucagon release in the ovine fetus.

Authors:  M Józwik; C Teng; R B Wilkening; G Meschia; J Tooze; M Chung; F C Battaglia
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

5.  Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation.

Authors:  J C Anthony; T G Anthony; S R Kimball; T C Vary; L S Jefferson
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

Review 6.  Exercise- and nutrient-controlled mechanisms involved in maintenance of the musculoskeletal mass.

Authors:  M J Rennie
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

7.  A deficiency or excess of dietary threonine reduces protein synthesis in jejunum and skeletal muscle of young pigs.

Authors:  Xu Wang; Shiyan Qiao; Yulong Yin; Longyao Yue; Zongyi Wang; Guoyao Wu
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

8.  Placental transport of leucine and lysine is reduced in intrauterine growth restriction.

Authors:  T Jansson; V Scholtbach; T L Powell
Journal:  Pediatr Res       Date:  1998-10       Impact factor: 3.756

9.  Placental transport and fetal utilization of leucine in a model of fetal growth retardation.

Authors:  J C Ross; P V Fennessey; R B Wilkening; F C Battaglia; G Meschia
Journal:  Am J Physiol       Date:  1996-03

10.  Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep.

Authors:  Paul J Rozance; Sean W Limesand; James S Barry; Laura D Brown; Stephanie R Thorn; Dan LoTurco; Timothy R H Regnault; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-04       Impact factor: 4.310

View more
  20 in total

1.  Prolonged infusion of amino acids increases leucine oxidation in fetal sheep.

Authors:  Anne M Maliszewski; Monika M Gadhia; Meghan C O'Meara; Stephanie R Thorn; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

2.  Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep.

Authors:  Laura D Brown; Paul J Rozance; Stephanie R Thorn; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

3.  A Chronic Fetal Leucine Infusion Potentiates Fetal Insulin Secretion and Increases Pancreatic Islet Size, Vascularity, and β Cells in Late-Gestation Sheep.

Authors:  Brit H Boehmer; Laura D Brown; Stephanie R Wesolowski; William W Hay; Paul J Rozance
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

4.  Coordinated changes in hepatic amino acid metabolism and endocrine signals support hepatic glucose production during fetal hypoglycemia.

Authors:  Satya S Houin; Paul J Rozance; Laura D Brown; William W Hay; Randall B Wilkening; Stephanie R Thorn
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

5.  Prolonged amino acid infusion into intrauterine growth-restricted fetal sheep increases leucine oxidation rates.

Authors:  Sandra G Wai; Paul J Rozance; Stephanie R Wesolowski; William W Hay; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-09-11       Impact factor: 4.310

Review 6.  The impact of IUGR on pancreatic islet development and β-cell function.

Authors:  Brit H Boehmer; Sean W Limesand; Paul J Rozance
Journal:  J Endocrinol       Date:  2017-08-14       Impact factor: 4.286

7.  Characterization of glucose-insulin responsiveness and impact of fetal number and sex difference on insulin response in the sheep fetus.

Authors:  Alice S Green; Antoni R Macko; Paul J Rozance; Dustin T Yates; Xiaochuan Chen; William W Hay; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-22       Impact factor: 4.310

8.  Thoracic and abdominal aortas stiffen through unique extracellular matrix changes in intrauterine growth restricted fetal sheep.

Authors:  R Blair Dodson; Paul J Rozance; Carson C Petrash; Kendall S Hunter; Virginia L Ferguson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

9.  Increased arterial stiffness and extracellular matrix reorganization in intrauterine growth-restricted fetal sheep.

Authors:  Reuben Blair Dodson; Paul J Rozance; Bradley S Fleenor; Carson C Petrash; Lauren G Shoemaker; Kendall S Hunter; Virginia L Ferguson
Journal:  Pediatr Res       Date:  2012-11-15       Impact factor: 3.756

10.  Hyperelastic remodeling in the intrauterine growth restricted (IUGR) carotid artery in the near-term fetus.

Authors:  R Blair Dodson; Paul J Rozance; Esther Reina-Romo; Virginia L Ferguson; Kendall S Hunter
Journal:  J Biomech       Date:  2013-01-16       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.